Clinical trials of a new immunotherapy, pembrolizumab, have shown that it prolongs life significantly for patients with bladder cancer and is active against a rare sub-type of melanoma, called mucosal melanoma.
from Top Health News – ScienceDaily http://ift.tt/2kIqyIS
from Tumblr http://ift.tt/2khGUHS
No comments:
Post a Comment